Comprehensive cardiovascular risk management – what does it mean in practice?

References

• Alm-RoijerCFridlundBStagmoMKnowing your risk factors for coronary heart disease improves adherence to advice on lifestyle changes and medicationJ Cardiovasc Nursing200621E24E31
   PubMedGoogle Scholar
• [AHA] American Heart AssociationInternational cardiovascular disease statistics2003Dallas, TexasAmerican Heart Association
   Google Scholar
• AnsellBJEvidence for a combined approach to the management of hypertension and dyslipidemiaAm J Hypertens20051812495716245413
   PubMed Web of Science ®Google Scholar
• AsmarRVolSPannierBHigh blood pressure and associated cardiovascular risk factors in FranceJ Hypertens20011917273211593091
   PubMed Web of Science ®Google Scholar
• AvornJMonetteJLacourAPersistence of use of lipid-lowering medications:a cross-national studyJAMA19982791458629600480
   PubMed Web of Science ®Google Scholar
• BacklundLBringJStrenderJ-EHow accurately do general practitioners and students estimate coronary risk in hypercholesterolaemic patientsPrimary Health Care Research and Development2004514552
   Google Scholar
• BaigentCKeechAKearneyPMEfficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statinsLancet200536612677816214597
   PubMed Web of Science ®Google Scholar
• BaoWSrinivasanSRWattigneyWAPersistence of multiple cardiovascular risk clustering related to syndrome X from childhood to young adulthood. The Bogalusa Heart StudyArch Intern Med1994154184278053753
   PubMed Web of Science ®Google Scholar
• BarterPThe inflammation: lipoprotein cycleAtheroscler Suppl20056152015823492
   PubMed Web of Science ®Google Scholar
• BarthJCritchleyJBengelJEfficacy of psychosocial interventions for smoking cessation in patients with coronary heart disease:a systematic review and meta-analysisAnn Behav Med200632102016827625
   PubMed Web of Science ®Google Scholar
• BautistaLEVeraLMArenasIAIndependent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-alpha) and essential hypertensionJ Hum Hypertens2005191495415361891
   PubMed Web of Science ®Google Scholar
• BhattDLStegPGOhmanEMInternational prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosisJAMA2006295180916403930
   PubMed Web of Science ®Google Scholar
• BlankRLaSalleJReevesRSingle-pill therapy in the treatment of concomitant hypertension and dyslipidemia (The Amlodipine/Atorvastatin Gemini Study)J Clin Hypertens2005726473
   PubMedGoogle Scholar
• BolandLLFolsomARSorliePDOccurrence of unrecognized myocardial infarction in subjects aged 45 to 65 years (the ARIC study)Am J Cardiol2002909273112398956
   PubMed Web of Science ®Google Scholar
• BonettiPOLermanLOLermanAEndothelial dysfunction: a marker of atherosclerotic riskArterioscler Thromb Vasc Biol2003231687512588755
   PubMed Web of Science ®Google Scholar
• BoothGLKapralMKFungKRelation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort studyLancet2006368293616815377
   PubMed Web of Science ®Google Scholar
• CabanaMDRandCSPoweNRWhy don’t physicians follow clinical practice guidelines? A framework for improvementJAMA199928214586510535437
   PubMed Web of Science ®Google Scholar
• CampbellNCThainJDeansHGSecondary prevention clinics for coronary heart disease: randomized trial of effect on healthBMJ1998316143479572758
   PubMed Web of Science ®Google Scholar
• CannonCPBraunwaldMDMcCabeCHIntensive and moderate lipid lowering with statins after acute coronary symptomsN Engl J Med2004350149550415007110
   PubMed Web of Science ®Google Scholar
• ChapmanRHBennerJSPetrillaAAPredictors of adherence with antihypertensive and lipid-lowering therapyArch Intern Med200516511475215911728
   PubMed Web of Science ®Google Scholar
• ChiuveSEMcCulloughMLSacksFMHealthy lifestyle factors in the primary prevention of coronary heart disease among menCirculation2006114160716818808
   PubMed Web of Science ®Google Scholar
• ChobanianAVBakrisGLBlackHRThe seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: The JNC 7 ReportJAMA200328925607212748199
   PubMed Web of Science ®Google Scholar
• ConroyRMPyoralaKFitzgeraldAPEstimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE projectEur Heart J200324987100312788299
   PubMed Web of Science ®Google Scholar
• De BackerGAmbrosioniEBorch-JohnsenKEuropean guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical PracticeEur Heart J20032416011012964575
   PubMed Web of Science ®Google Scholar
• De MuylderRLorantVPaulusDObstacles to cardiovascular prevention in general practiceActa Cardiol2004591192515139651
   PubMed Web of Science ®Google Scholar
• DrouinDCampbellNRKaczorowskiJImplementation of recommendations on hypertension: the Canadian Hypertension Education ProgramCan J Cardiol200622595816755314
   PubMed Web of Science ®Google Scholar
• EdelmanDOddoneEZLiebowitzRSA multidimensional integrative medicine intervention to improve cardiovascular riskJ Gen Intern Med2006217283416808774
   PubMed Web of Science ®Google Scholar
• EgedeLEImplementing behavioral counseling interventions in primary care to modify cardiovascular risk in adults with diabetesCardiovasc Rev Rep20032430612
   Google Scholar
• EmbersonJRWhincupPHMorrisRWReassessing the contribution of serum total cholesterol, blood pressure and cigarette smoking to the aetiology of coronary heart disease: impact of regression dilution biasEur Heart J20032417192614522566
   PubMed Web of Science ®Google Scholar
• EmbersonJWhincupPMorrisRWEvaluating the impact of population and high-risk strategies for The primary prevention of cardiovascular diseaseEur Heart J2004254849115039128
   PubMed Web of Science ®Google Scholar
• ErhardtLRPearsonTABruckertEGuidelines and their implementation: a discussion document focused on the best appraches to drive improvementVascular Disease Prevention20041166774
   Google Scholar
• EUROASPIRE I and II GroupClinical reality of coronary prevention guidelines:a comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce EventsLancet2001357995100111293642
   PubMed Web of Science ®Google Scholar
• FaergemanOChallenges to best practice: Why are guidelines not implementedEur Heart J Suppl19991Suppl JJ12J17
   Web of Science ®Google Scholar
• FelmedenDCSpencerCGBlannADLow-density lipoprotein subfractions and cardiovascular risk in hypertension: relationship to endothelial dysfunction and effects of treatmentHypertension2003415283312623954
   PubMed Web of Science ®Google Scholar
• GaedePVedelPLarsenNMultifactorial intervention and cardiovascular disease in patients with type 2 diabetesN Engl J Med20033483839312556541
   PubMed Web of Science ®Google Scholar
• GilesTDBerkBCBlackHRExpanding the definition and classification of hypertensionJ Clin Hypertens2005750512
   PubMedGoogle Scholar
• GohlkeHKWinterMKaroffMCARRISMA: a new tool to optimize cardiovascular risk management in primary prevention [abstract]Circulation2005123794 Abstract
   Google Scholar
• GreenlandPKnollMDStamlerJMajor risk factors as antecedents of fatal and nonfatal coronary heart disease eventsJAMA2003290891712928465
   PubMed Web of Science ®Google Scholar
• GrimmRJnrSvendsenKCardiovascular risk meter: A device for rapid estimation of cardiovascular disease mortality in clinical settingsJ Clin Hypertens20068Suppl A 5A236P-577MP-55 abstract
   Google Scholar
• GroverSAHemmelgarnBJosephLThe role of global risk assessment in hypertension therapyCan J Cardiol2006226061316755316
   PubMed Web of Science ®Google Scholar
• HaffnerSMLehtoSRonnemaaTMortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarctionN Engl J Med1998339229349673301
   PubMed Web of Science ®Google Scholar
• HoPMRumsfeldJSMasoudiFAEffect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitusArch Intern Med2006a16618364117000939
   PubMed Web of Science ®Google Scholar
• HoPMSpertusJAMasoudiFAImpact of medication therapy discontinuation on mortality after myocardial infarctionArch Intern Med2006b1661842717000940
   PubMed Web of Science ®Google Scholar
• HobbsFDErhardtLAcceptance of guideline recommendations and perceived implementation of coronary heart disease prevention among primary care physicians in five European countries: the Reassessing European Attitudes about Cardiovascular Treatment (REACT) surveyFam Pract20021959660412429661
   PubMed Web of Science ®Google Scholar
• HuxleyRBarziFWoodwardMExcess of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studiesBMJ200633273816371403
   PubMed Web of Science ®Google Scholar
• International Diabetes FederationDiabetes Atlas3 [online]. URL: http://www.eatlas.idf.org/media/
   Google Scholar
• JacksonRLawesCMBennettDATreatment with drugs to lower blood pressure and blood cholesterol based on an individual’s absolute cardiovascular riskLancet20053654344115680460
   PubMed Web of Science ®Google Scholar
• JohnsonMLPietzKBattlemanDSTherapeutic goal attainment in patients with hypertension and dyslipidemiaMed Care200644394616365611
   PubMed Web of Science ®Google Scholar
• Joint British SocietiesJBS 2: Joint British Societies’ guidelines on prevention of cardiovascular disease in clinical practiceHeart200591Suppl 5v1v5216365341
   PubMedGoogle Scholar
• JuliusSKjeldsenSEWeberMOutcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trialLancet200436320223115207952
   PubMed Web of Science ®Google Scholar
• KannelWBFifty years of Framingham Study contributions to understanding hypertensionJ Hum Hypertens2000a14839010723112
   PubMed Web of Science ®Google Scholar
• KannelWBRisk stratification in hypertension: new insights from the Framingham StudyAm J Hypertens2000b133S10S10678282
   PubMed Web of Science ®Google Scholar
• KhanNAMcAlisterFARabkinSWThe 2006 Canadian hypertension education program recommendations for the management of hypertension: Part II – TherapyCan J Cardiol2006225839316755313
   PubMed Web of Science ®Google Scholar
• KnappPRaynorDKBerryDCComparison of two methods of presenting risk information to patients about the side effects of medicinesQual Saf Health Care2004131768015175486
   PubMed Web of Science ®Google Scholar
• LawMRWaldNJThompsonSGBy how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart diseaseBMJ1994308367728043072
   PubMed Web of Science ®Google Scholar
• LernerDJKannelWBPatterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham populationAm Heart J1986111383903946178
   PubMed Web of Science ®Google Scholar
• LiaoDMoJDuanYThe joint effect of hypertension and elevated LDL-cholesterol on CHD is beyond additiveEur Heart J200425abstract suppl235 abstract #1377
   Google Scholar
• Lloyd-JonesDMLeipEPLarsonMGPrediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of ageCirculation2006113791816461820
   PubMed Web of Science ®Google Scholar
• LynchTMedication costs as a primary cause of nonadherence in the elderlyConsult Pharm200621143616524358
   PubMedGoogle Scholar
• MacGregorKHandleyMWongSBehavior-change action plans in primary care: a feasibility study of cliniciansJ Am Board Fam Med2006192152316672674
   PubMed Web of Science ®Google Scholar
• MacMahonSRodgersABlood pressure, antihypertensive treatment and stroke riskJ Hypertens Suppl199412S5S147769492
   PubMedGoogle Scholar
• McManusBINTERHEART: nine factors that could save your lifeHealthc Q200582815715328
   PubMedGoogle Scholar
• McMurrayJThe health economics of the treatment of hyperlipidemia and hypertensionAm J Hypertens19991299S104S10555609
   PubMed Web of Science ®Google Scholar
• ManciaGTotal cardiovascular risk:a new treatment conceptJ Hypertens Suppl200624S17S2416601556
   PubMedGoogle Scholar
• ManciaGDe BackerGDominiczakA2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)J Hypertens20072511058717563527
   PubMed Web of Science ®Google Scholar
• Medical Research CouncilWhy 6g? A summary of the scientific evidence for the salt intake target2006CambridgeMedical Research Council
   Google Scholar
• MeyerGMervalRTedguiAEffects of pressure-induced stretch and convection on low-density lipoprotein and albumin uptake in the rabbit aortic wallCirc Res199679532408781486
   PubMed Web of Science ®Google Scholar
• MurrayCJLopezADAlternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease StudyLancet199734914985049167458
   PubMed Web of Science ®Google Scholar
• NatarajanSLiaoYCaoGSex differences in risk for coronary heart disease mortality associated with diabetes and established coronary heart diseaseArch Intern Med200316317354012885690
   PubMedGoogle Scholar
• National Cholesterol Education ProgramExecutive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)JAMA200128524869711368702
   PubMed Web of Science ®Google Scholar
• NeatonJDWentworthDSerum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Multiple Risk Factor Intervention Trial Research GroupArch Intern Med199215256641728930
   PubMed Web of Science ®Google Scholar
• NissenSETuzcuEMSchoenhagenPEffect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis:a randomized controlled trialJAMA200429110718014996776
   PubMed Web of Science ®Google Scholar
• O’MearaJGKardiaSLArmonJJEthnic and sex differences in the prevalence, treatment, and control of dyslipidemia among hypertensive adults in the GENOA studyArch Intern Med200416413131815226165
   PubMed Web of Science ®Google Scholar
• PiloteLHoVLavoieFCost-effectiveness of lipid-lowering treatment according to lipid levelCan J Cardiol200521681716003451
   PubMed Web of Science ®Google Scholar
• PlummerCJWhat’s in the CARDSDiab Med20062371114
   PubMed Web of Science ®Google Scholar
• PrimatestaPPoulterNRLipid concentrations and the use of lipid lowering drugs:evidence from a national cross sectional surveyBMJ20003211322511090516
   PubMed Web of Science ®Google Scholar
• PuskaPComprehensive cardiovascular community control programmes in Europe1988CopenhagenWHO Regional Office for Europe EURO Reports and Studies 106
   Google Scholar
• PuskaPVartiainenETuomilehtoJChanges in premature deaths in Finland:successful long-term prevention of cardiovascular diseasesBull World Health Organ199876419259803593
   PubMed Web of Science ®Google Scholar
• RakugiHYuHKamitaniALinks between hypertension and myocardial infarctionAm Heart J1996132213218677859
   PubMed Web of Science ®Google Scholar
• RaynerMEuropean Cardiovascular Disease Statistics2000
   Google Scholar
• ReavenGMLithellHLandsbergLHypertension and associated metabolic abnormalities – the role of insulin resistance and the sympathoadrenal systemN Engl J Med1996334374818538710
   PubMed Web of Science ®Google Scholar
• Rodriguez-PorcelMLermanLOHerrmannJHypercholesterolemia and hypertension have synergistic deleterious effects on coronary endothelial functionArterioscler Thromb Vasc Biol2003238859112663373
   PubMed Web of Science ®Google Scholar
• RosamondWFlegalKFridayGHeart disease and stroke statistics–2007 update:a report from the American Heart Association Statistics Committee and Stroke Statistics SubcommitteeCirculation2007115e69e17117194875
   PubMed Web of Science ®Google Scholar
• SafranGNeumanPSchoenCPrescription drug coverage and seniors: findings from a 2003 national surveyHealth Aff2005Jan-JunSuppl Web ExclusivesW5-152W5-166
   Google Scholar
• SamuelssonOWilhelmsenLAnderssonOKCardiovascular morbidity in relation to change in blood pressure and serum cholesterol levels in treated hypertension. Results from the primary prevention trial in Goteborg, SwedenJAMA19872581768763625987
   PubMed Web of Science ®Google Scholar
• SeverPSDahlöfBPoulterNRPrevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial–Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trialLancet200336111495812686036
   PubMed Web of Science ®Google Scholar
• SimpsonEBeckCRichardHDrug prescriptions after acute myocardial infarction:dosage, compliance, and persistenceAm Heart J20031454384412660666
   PubMed Web of Science ®Google Scholar
• SoumeraiSBPierre-JacquesMZhangFCost-related medication nonadherence among elderly and disabled Medicare beneficiaries:a national survey 1 year before the medicare drug benefitArch Intern Med200616618293517000938
   PubMed Web of Science ®Google Scholar
• StamlerJVaccaroONeatonJDDiabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention TrialDiabetes Care199316434448432214
   PubMed Web of Science ®Google Scholar
• SullivanLMMassaroJMD’AgostinoRBSrPresentation of multivariate data for clinical use:The Framingham Study risk score functionsStat Med20042316316015122742
   PubMed Web of Science ®Google Scholar
• ThomasFBeanKGuizeLCombined effects of systolic blood pressure and serum cholesterol on cardiovascular mortality in young (<55 years) men and womenEur Heart J2002235283511922642
   PubMed Web of Science ®Google Scholar
• ThomasTSImproving care with nurse case managers:practical aspects of designing lipid clinicsAm J Cardiol19978062H65H
   PubMed Web of Science ®Google Scholar
• ThomsenTFDavidsenMIbsenHA new method for CHD prediction and prevention based on regional risk scores and randomized clinical trials; PRECARD and the Copenhagen Risk ScoreJ Cardiovasc Risk20018291711702035
   PubMedGoogle Scholar
• TurnbullFEffects of different blood-pressure-lowering regimens on major cardiovascular events:results of prospectively-designed overviews of randomised trialsLancet200336215273514615107
   PubMed Web of Science ®Google Scholar
• VartiainenEPuskaPPekkanenJChanges in risk factor explain changes in mortality from ischaemic heart disease in FinlandBMJ19943092378044063
   PubMed Web of Science ®Google Scholar
• VasanRSBeiserASeshadriSResidual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart StudyJAMA200228710031011866648
   PubMed Web of Science ®Google Scholar
• WaldNJLawMRA strategy to reduce cardiovascular disease by more than 80%BMJ2003326141912829553
   PubMed Web of Science ®Google Scholar
• WeiLWangJThompsonPAdherence to statin treatment and readmission of patients after myocardial infarction:a six year follow up studyHeart2002882293312181210
   PubMed Web of Science ®Google Scholar
• WildSRoglicGGreenAGlobal prevalence of diabetes:estimates for the year 2000 and projections for 2030Diabetes Care20042710475315111519
   PubMed Web of Science ®Google Scholar
• WilsonPWD’AgostinoRBLevyDPrediction of coronary heart disease using risk factor categoriesCirculation1998971837479603539
   PubMed Web of Science ®Google Scholar
• WongNDLopezVTangSPrevalence, treatment, and control of combined hypertension and hypercholesterolemia in the United StatesAm J Cardiol200698204816828593
   PubMed Web of Science ®Google Scholar
• [WHO] World Health OrganizationCardiovascular disease:prevention and control2005GenevaWorld Health Organization
   Google Scholar
• YoonKHLeeJHKimJWEpidemic obesity and type 2 diabetes in AsiaLancet20063681681817098087
   PubMed Web of Science ®Google Scholar
• YusufSHawkenSOunpuuSEffect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study):case-control studyLancet20043649375215364185
   PubMed Web of Science ®Google Scholar
• ZimmermanEMHorton-La ForgeBDetection and prevention of cardiac risk factors:health risk assessment and targeted follow-up in a managed care populationJ Cardiovasc Nurs19961127389069029
   PubMedGoogle Scholar